Clinical trial
Therapy for Children With Advanced Stage High Risk Neuroblastoma
NCT00186849 · St. Jude Children's Research Hospital, Other · Completed
Key facts
| NCT number | NCT00186849 |
|---|---|
| Title | Therapy for Children With Advanced Stage High Risk Neuroblastoma |
| Official title | Therapy for Children With Advanced Stage High Risk Neuroblastoma |
| Lead sponsor | St. Jude Children's Research Hospital, Other |
| Collaborators | National Institutes of Health (NIH) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Neuroblastoma |
| Intervention type | Drug, Procedure |
| Interventions | Topotecan, Cyclophosphamide, Cisplatin, Doxorubicin, Etoposide, Ifosfamide, Carboplatin, Peripheral Blood Stem Cell Transplant |
| Enrollment | 30 |
| Start date | Oct 1, 1997 |
| Primary completion | Apr 1, 2001 |
| Completion | Apr 1, 2001 |
| First posted | Sep 16, 2005 |
| Last update posted | May 20, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: